| RAPT THERAPEUTICS |
| USA |
| Gesundheit |
| US75382E2081 / A418SN |
| 0RA0 (Frankfurt) / RAPT (NASDAQ) |
| FRA:0RA0, ETR:0RA0, 0RA0:GR, NASDAQ:RAPT |
| - |
| https://rapt.com/ |
|
RAPT Therapeutics, Inc. operates as a clinical-sta..
>Volltext.. |
| 769.08 Mio. EUR |
| 637.11 Mio. EUR |
| - |
| -94.27 Mio. EUR |
| -91.08 Mio. EUR |
| -9.54 EUR |
| 2.24 Mio. EUR |
| 32.7 Mio. EUR |
| -74.65 Mio. EUR |
| 11.76 |
| - |
| 6.75% |
| - |
| - |
| - |
| - |
| RAPT THERAPEUTICS, RAPT THERAPEUTIC |
| 20.01.26 |
|